The ClinicianThe ClinicianКлиницист1818-83382412-8775Publishing House ABV Press13110.17650/1818-8338-2011-1-14-17REVIEWОБЗОРCHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: NEW ASPECTS OF THE DEVELOPMENT AND PROGRESSION OF THE DISEASEХРОНИЧЕСКАЯ ПОСТЭМБОЛИЧЕСКАЯ ЛЕГОЧНАЯ ГИПЕРТЕНЗИЯ: НОВЫЕ АСПЕКТЫ ФОРМИРОВАНИЯ И ПРОГРЕССИРОВАНИЯ ЗАБОЛЕВАНИЯKlimenkoA. A.КлименкоА. А.
Russian Federation

Acad. A.I. Nesterov Department of Faculty Therapy

Кафедра факультетской терапии им. акад. А.И. Нестерова

ShostakN. A.ШостакН. А.
Russian Federation

Acad. A.I. Nesterov Department of Faculty Therapy

Кафедра факультетской терапии им. акад. А.И. Нестерова

DemidovaN. A.ДемидоваН. А.
Russian Federation

Acad. A.I. Nesterov Department of Faculty Therapy

Кафедра факультетской терапии им. акад. А.И. Нестерова

ntverdova@yandex.ruNovikovI. V.НовиковИ. В.
Russian Federation

Acad. A.I. Nesterov Department of Faculty Therapy

Кафедра факультетской терапии им. акад. А.И. Нестерова

Russian State Medical University, Russian Agency for Health CareГОУ ВПО РГМУ Росздрава150120115114171807201418072014Copyright ©; 2011, Klimenko A.A., Shostak N.A., Demidova N.A., Novikov I.V.Copyright ©; 2011, Клименко А.А., Шостак Н.А., Демидова Н.А., Новиков И.В.2011Klimenko A.A., Shostak N.A., Demidova N.A., Novikov I.V.Клименко А.А., Шостак Н.А., Демидова Н.А., Новиков И.В.https://creativecommons.org/licenses/by/4.0https://klinitsist.abvpress.ru/Klin/article/view/131

The review presents data on the incidence of chronic thromboembolic pulmonary hypertension after pulmonary thromboembolism and describescongenital and acquired coagulation abnormalities in patients with venous thromboembolism. It considers the potential factors of development of chronic thromboembolic pulmonary hypertension and some medical conditions and diseases, which favors the development of pulmonary hypertension after prior pulmonary thromboembolism.

В обзоре представлены данные о частоте развития хронической постэмболической легочной гипертензии после тромбоэмболии легочной артерии, описаны врожденные и приобретенные аномалии коагуляции у пациентов с венозным тромбоэмболизмом. Рассмотрены потенциальные факторы формирования хронической постэмболической легочной гипертензии, а также некоторыемедицинские состояния и заболевания, способствующие развитию легочной гипертензии после перенесенной тромбоэмболии легочной артерии.

pulmonary hypertensionchronic thromboembolic pulmonary hypertensionpulmonary thromboembolismcongenital thrombophiliaлегочная гипертензияхроническая постэмболическая легочная гипертензиятромбоэмболия легочной артерииврожденная тромбофилия1. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений. Флебология 2010;(1):1–37.Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений. Флебология 2010;(1):1–37.2. McLaughlin V.V., Archer S.L., Badesch D.B., et al. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association Developed in Collaboration WithMcLaughlin V.V., Archer S.L., Badesch D.B., et al. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association Developed in Collaboration Withthe American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009;53:1573–619.3. Moser K.M., Auger W.R., Fedullo P.F. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation 1990;81:1735–43.Moser K.M., Auger W.R., Fedullo P.F. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation 1990;81:1735–43.4. Pengo V., Lensing A.W., Prins M.H., et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350:2257–64.Pengo V., Lensing A.W., Prins M.H., et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350:2257–64.5. Lang I.M. Chronic thromboembolic pulmonary hypertension – not so rare after all. N Engl J MedLang I.M. Chronic thromboembolic pulmonary hypertension – not so rare after all. N Engl J Med2004;350:2236–8.;350:2236–8.6. Dixon J.E., King M.A. Images in clinical medicine. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001;344(6):644.Dixon J.E., King M.A. Images in clinical medicine. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001;344(6):644.7. Lewczuk J., Piszko P., Jagas J., et al. Prognostic factors in medically treated patients with chronicLewczuk J., Piszko P., Jagas J., et al. Prognostic factors in medically treated patients with chronicpulmonary embolism. Chest 2001;119(3):818–23.8. Riedel M., Stanek V., Widimisky J., Prerovsky I. Longterm follow-up of patients with pulmonaryRiedel M., Stanek V., Widimisky J., Prerovsky I. Longterm follow-up of patients with pulmonarythromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest1982;81:151–8.;81:151–8.9. Bleasdale R., Frenneaux M. Prognostic importance of right ventricular dysfunction. HeartBleasdale R., Frenneaux M. Prognostic importance of right ventricular dysfunction. Heart2002;88:323–4.;88:323–4.10. Dartevelle P., Fadel E., Mussot S., et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004;23:637–48.Dartevelle P., Fadel E., Mussot S., et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004;23:637–48.11. Simpson E.L., Stevenson M.D., Rawdin A., Papaioannou D. Thrombophilia testing in people with venous thromboembolism: systematic review and cost-effectiveness analysis. Health TechnolSimpson E.L., Stevenson M.D., Rawdin A., Papaioannou D. Thrombophilia testing in people with venous thromboembolism: systematic review and cost-effectiveness analysis. Health TechnolAssess 2009;13(2):1–91.12. Martinelli I., Bucciarelli P., Margaglione M., et al. The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both. Br J HaematolMartinelli I., Bucciarelli P., Margaglione M., et al. The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both. Br J Haematol2000;111:1223–9.;111:1223–9.13. Lang I., Kerr K. Risk factors for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006;3:568–70.Lang I., Kerr K. Risk factors for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006;3:568–70.14. Lang I.M., Klepetko W., Pabinger I. No increased prevalence of the factor V mutationLang I.M., Klepetko W., Pabinger I. No increased prevalence of the factor V mutationin chronic major vessel thromboembolic pulmonary hypertension (CTEPH). Thromb Haemost 1996;76:476–7.15. Suntharalingam J., Goldsmith K., van Marion V., et al. Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension. Eur Respir J 2008;31:736–41.Suntharalingam J., Goldsmith K., van Marion V., et al. Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension. Eur Respir J 2008;31:736–41.16. Wong C.L., Szydlo R., Gibbs S., Laffan M. Hereditary and acquired thrombotic risk factorsWong C.L., Szydlo R., Gibbs S., Laffan M. Hereditary and acquired thrombotic risk factorsfor chronic thromboembolic pulmonary hypertension. Blood Coagul Fibrinolysis 2010;21(3):201–6.17. Mansilha A., Araujo F., Severo M., et al. Genetic polymorphisms and risk of recurrent deep venous thrombosis in young people: prospective cohort study. Eur J Vasc Endovasc Surg 2005;30:545–9.Mansilha A., Araujo F., Severo M., et al. Genetic polymorphisms and risk of recurrent deep venous thrombosis in young people: prospective cohort study. Eur J Vasc Endovasc Surg 2005;30:545–9.18. Varela M.L., Adamczuk Y.P., Forastiero R.R., et al. Major and potential prothrombotic genotypes in a cohort of patients with venous thromboembolism. Thromb Res 2001;104:317–24.Varela M.L., Adamczuk Y.P., Forastiero R.R., et al. Major and potential prothrombotic genotypes in a cohort of patients with venous thromboembolism. Thromb Res 2001;104:317–24.19. Wolf M., Boyer-Neumann C., Parent F., et al. Thrombotic risk factors in pulmonary hypertension. Eur Respir J 2000;15:395–9.Wolf M., Boyer-Neumann C., Parent F., et al. Thrombotic risk factors in pulmonary hypertension. Eur Respir J 2000;15:395–9.20. Ginsberg J.S., Wells P.S., Brill-Edwards P., et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995;86:3685–91.Ginsberg J.S., Wells P.S., Brill-Edwards P., et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995;86:3685–91.21. Бокарева И.Н., Попова Л.В., Козлова Т.В. Тромбозы и противотромботическая терапия в клинической практике. М.: МИА, 2009.Бокарева И.Н., Попова Л.В., Козлова Т.В. Тромбозы и противотромботическая терапия в клинической практике. М.: МИА, 2009.22. Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology. Eur Heart J 2000;21:1301–36.Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology. Eur Heart J 2000;21:1301–36.23. Bonderman D., Turecek P.L., Jakowitsch J., et al. High prevalence of elevated clotting factorBonderman D., Turecek P.L., Jakowitsch J., et al. High prevalence of elevated clotting factorVIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost 2003;90:372–6.24. Koster T., Blann A.D., Briet E., et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995;345:152–5.Koster T., Blann A.D., Briet E., et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995;345:152–5.25. Egermayer P., Peacock A.J. Is pulmonary embolism a common cause of chronic pulmonaryEgermayer P., Peacock A.J. Is pulmonary embolism a common cause of chronic pulmonaryhypertension? Limitations of the embolic hypothesis. Eur Respir J 2000;15:440–8.26. Morris T.A., Marsh J.J., Chiles P.G., et al. High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood 2009;114(9):1929–36.Morris T.A., Marsh J.J., Chiles P.G., et al. High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood 2009;114(9):1929–36.27. Carr M.E. Jr., Alving B.M. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots. Blood Coagul Fibrinolysis 1995;6(6):567–73.Carr M.E. Jr., Alving B.M. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots. Blood Coagul Fibrinolysis 1995;6(6):567–73.28. Fedullo P.F., Auger W.R., Kerr K.M., Rubin L.J. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001;345:1465–72.Fedullo P.F., Auger W.R., Kerr K.M., Rubin L.J. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001;345:1465–72.29. Bonderman D., Skoro-Sajer N., Jakowitsch J. Predictors of outcome in chronic thromboembolicBonderman D., Skoro-Sajer N., Jakowitsch J. Predictors of outcome in chronic thromboembolicpulmonary hypertension. Circulation 2007;115:2153–8.30. Bonderman D., Wilkens H., Wakounig S., et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J 2009;33(2):325–31.Bonderman D., Wilkens H., Wakounig S., et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J 2009;33(2):325–31.